Integrated protein and metabolite analysis open the door to more precise ways of guiding treatment for the nearly 70 million people worldwide who annually suffer traumatic brain injuries
Alex Yiu, whose rare neurological disorder was diagnosed by TGen, will celebrate a combination birthday and ‘Perseverance’ pre-launch party and fundraiser on July 25
Ashion Analytics GEMExTra test detects rare NRG1 gene fusions in patients whose cancer is driven by this genomic alteration for potential matching to a clinical trial
Physician-scientists are using one of the world’s most comprehensive genomic analysis tools to determine whether targeted therapy or immunotherapy has the best chance of working for each individual patient
New PATRIOT analysis unveiled at this week’s AACR meeting; builds on Ashion’s GEM-ExTra program, providing unprecedented accuracy in prescribing anti-cancer treatments